Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.
Hahn AW, Surasi DS, Viscuse PV, Bathala TK, Wiele AJ, Campbell MT, Zurita AJ, Shah AY, Jonasch E, Gao J, Goswami S, Alhalabi O, Rao P, Sircar K, Tannir NM, Msaouel P. Hahn AW, et al. Among authors: campbell mt. Oncologist. 2024 May 3;29(5):392-399. doi: 10.1093/oncolo/oyad302. Oncologist. 2024. PMID: 38035767 Free PMC article.
Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma.
Campbell MT, Millikan RE, Altinmakas E, Xiao L, Wen SJ, Siefker-Radtke AO, Aparicio A, Corn PG, Tannir NM. Campbell MT, et al. Clin Genitourin Cancer. 2015 Jun;13(3):218-24. doi: 10.1016/j.clgc.2014.10.004. Epub 2014 Oct 24. Clin Genitourin Cancer. 2015. PMID: 25465491 Free PMC article. Clinical Trial.
Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.
Matrana MR, Bathala T, Campbell MT, Duran C, Shetty A, Teegavarapu P, Kalra S, Xiao L, Atkinson B, Corn P, Jonasch E, Tannir NM. Matrana MR, et al. Among authors: campbell mt. BJU Int. 2016 Aug;118(2):264-71. doi: 10.1111/bju.13374. Epub 2015 Dec 13. BJU Int. 2016. PMID: 26573089 Free PMC article.
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. Bilen MA, et al. Among authors: campbell mt. Oncotarget. 2016 Dec 27;7(52):86280-86289. doi: 10.18632/oncotarget.13380. Oncotarget. 2016. PMID: 27861143 Free PMC article.
Recent developments in the management of germ cell tumors.
Msaouel P, Bilen MA, Zhang M, Campbell M, Wang J, Tu SM. Msaouel P, et al. Curr Opin Oncol. 2017 May;29(3):172-178. doi: 10.1097/CCO.0000000000000361. Curr Opin Oncol. 2017. PMID: 28151756 Free PMC article.
Optimizing management of upper tract urothelial carcinoma.
Campbell MT, Shah AY, Matin SF, Siefker-Radtke AO. Campbell MT, et al. Urol Oncol. 2017 Jul;35(7):492-498. doi: 10.1016/j.urolonc.2017.05.009. Epub 2017 Jun 1. Urol Oncol. 2017. PMID: 28579283 Review.
160 results